aluates Reports

$ 0.0

Automative

Global Osteoarthritis Medications Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-28E5704

Global Osteoarthritis Medications Market Insights Forecast to 2028

BUY CHAPTERS

Global Osteoarthritis Medications Market Research Report 2024

Code: QYRE-Auto-28E5704

Report

March 2024

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Osteoarthritis Medications Market Size

The global Osteoarthritis Medications market was valued at US$ 9238 million in 2023 and is anticipated to reach US$ 11720 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.

Osteoarthritis Medications Market

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Osteoarthritis Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteoarthritis Medications.

Report Scope

The Osteoarthritis Medications market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Osteoarthritis Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Osteoarthritis Medications companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Osteoarthritis Medications Market Report

Report Metric	Details
Report Name	Osteoarthritis Medications Market
Accounted market size in 2023	US$ 9238 million
Forecasted market size in 2030	US$ 11720 million
CAGR	3.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	NSAIDs Corticosteroids Hyaluronic Acid Injection Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, Eli Lilly, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma, Flexion Therapeutics, Anika Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Osteoarthritis Medications companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Osteoarthritis Medications Market growing?

Ans: The Osteoarthritis Medications Market witnessing a CAGR of 3.4% during the forecast period 2024-2030.

What is the Osteoarthritis Medications Market size in 2030?

Ans: The Osteoarthritis Medications Market size in 2030 will be US$ 11720 million.

Who are the main players in the Osteoarthritis Medications Market report?

Ans: The main players in the Osteoarthritis Medications Market are Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, Eli Lilly, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma, Flexion Therapeutics, Anika Therapeutics

What are the Application segmentation covered in the Osteoarthritis Medications Market report?

Ans: The Applications covered in the Osteoarthritis Medications Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Osteoarthritis Medications Market report?

Ans: The Types covered in the Osteoarthritis Medications Market report are NSAIDs, Corticosteroids, Hyaluronic Acid Injection, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Osteoarthritis Medications Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 NSAIDs

1.2.3 Corticosteroids

1.2.4 Hyaluronic Acid Injection

1.2.5 Others

1.3 Market by Application

1.3.1 Global Osteoarthritis Medications Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Osteoarthritis Medications Market Perspective (2019-2030)

2.2 Osteoarthritis Medications Growth Trends by Region

2.2.1 Global Osteoarthritis Medications Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Osteoarthritis Medications Historic Market Size by Region (2019-2024)

2.2.3 Osteoarthritis Medications Forecasted Market Size by Region (2025-2030)

2.3 Osteoarthritis Medications Market Dynamics

2.3.1 Osteoarthritis Medications Industry Trends

2.3.2 Osteoarthritis Medications Market Drivers

2.3.3 Osteoarthritis Medications Market Challenges

2.3.4 Osteoarthritis Medications Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Osteoarthritis Medications Players by Revenue

3.1.1 Global Top Osteoarthritis Medications Players by Revenue (2019-2024)

3.1.2 Global Osteoarthritis Medications Revenue Market Share by Players (2019-2024)

3.2 Global Osteoarthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Osteoarthritis Medications Revenue

3.4 Global Osteoarthritis Medications Market Concentration Ratio

3.4.1 Global Osteoarthritis Medications Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Osteoarthritis Medications Revenue in 2023

3.5 Osteoarthritis Medications Key Players Head office and Area Served

3.6 Key Players Osteoarthritis Medications Product Solution and Service

3.7 Date of Enter into Osteoarthritis Medications Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Osteoarthritis Medications Breakdown Data by Type

4.1 Global Osteoarthritis Medications Historic Market Size by Type (2019-2024)

4.2 Global Osteoarthritis Medications Forecasted Market Size by Type (2025-2030)

5 Osteoarthritis Medications Breakdown Data by Application

5.1 Global Osteoarthritis Medications Historic Market Size by Application (2019-2024)

5.2 Global Osteoarthritis Medications Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Osteoarthritis Medications Market Size (2019-2030)

6.2 North America Osteoarthritis Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Osteoarthritis Medications Market Size by Country (2019-2024)

6.4 North America Osteoarthritis Medications Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Osteoarthritis Medications Market Size (2019-2030)

7.2 Europe Osteoarthritis Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Osteoarthritis Medications Market Size by Country (2019-2024)

7.4 Europe Osteoarthritis Medications Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Osteoarthritis Medications Market Size (2019-2030)

8.2 Asia-Pacific Osteoarthritis Medications Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Osteoarthritis Medications Market Size by Region (2019-2024)

8.4 Asia-Pacific Osteoarthritis Medications Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Osteoarthritis Medications Market Size (2019-2030)

9.2 Latin America Osteoarthritis Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Osteoarthritis Medications Market Size by Country (2019-2024)

9.4 Latin America Osteoarthritis Medications Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Osteoarthritis Medications Market Size (2019-2030)

10.2 Middle East & Africa Osteoarthritis Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Osteoarthritis Medications Market Size by Country (2019-2024)

10.4 Middle East & Africa Osteoarthritis Medications Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Osteoarthritis Medications Introduction

11.1.4 Pfizer Revenue in Osteoarthritis Medications Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Osteoarthritis Medications Introduction

11.2.4 Johnson & Johnson Revenue in Osteoarthritis Medications Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Detail

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Osteoarthritis Medications Introduction

11.3.4 GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2019-2024)

11.3.5 GlaxoSmithKline Recent Development

11.4 Novartis

11.4.1 Novartis Company Detail

11.4.2 Novartis Business Overview

11.4.3 Novartis Osteoarthritis Medications Introduction

11.4.4 Novartis Revenue in Osteoarthritis Medications Business (2019-2024)

11.4.5 Novartis Recent Development

11.5 Bayer

11.5.1 Bayer Company Detail

11.5.2 Bayer Business Overview

11.5.3 Bayer Osteoarthritis Medications Introduction

11.5.4 Bayer Revenue in Osteoarthritis Medications Business (2019-2024)

11.5.5 Bayer Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Detail

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Osteoarthritis Medications Introduction

11.6.4 Eli Lilly Revenue in Osteoarthritis Medications Business (2019-2024)

11.6.5 Eli Lilly Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Detail

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Osteoarthritis Medications Introduction

11.7.4 Sanofi Revenue in Osteoarthritis Medications Business (2019-2024)

11.7.5 Sanofi Recent Development

11.8 Horizon Pharma

11.8.1 Horizon Pharma Company Detail

11.8.2 Horizon Pharma Business Overview

11.8.3 Horizon Pharma Osteoarthritis Medications Introduction

11.8.4 Horizon Pharma Revenue in Osteoarthritis Medications Business (2019-2024)

11.8.5 Horizon Pharma Recent Development

11.9 Abbott

11.9.1 Abbott Company Detail

11.9.2 Abbott Business Overview

11.9.3 Abbott Osteoarthritis Medications Introduction

11.9.4 Abbott Revenue in Osteoarthritis Medications Business (2019-2024)

11.9.5 Abbott Recent Development

11.10 Mylan

11.10.1 Mylan Company Detail

11.10.2 Mylan Business Overview

11.10.3 Mylan Osteoarthritis Medications Introduction

11.10.4 Mylan Revenue in Osteoarthritis Medications Business (2019-2024)

11.10.5 Mylan Recent Development

11.11 Daiichi Sankyo

11.11.1 Daiichi Sankyo Company Detail

11.11.2 Daiichi Sankyo Business Overview

11.11.3 Daiichi Sankyo Osteoarthritis Medications Introduction

11.11.4 Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2019-2024)

11.11.5 Daiichi Sankyo Recent Development

11.12 TEVA

11.12.1 TEVA Company Detail

11.12.2 TEVA Business Overview

11.12.3 TEVA Osteoarthritis Medications Introduction

11.12.4 TEVA Revenue in Osteoarthritis Medications Business (2019-2024)

11.12.5 TEVA Recent Development

11.13 Almatica Pharma

11.13.1 Almatica Pharma Company Detail

11.13.2 Almatica Pharma Business Overview

11.13.3 Almatica Pharma Osteoarthritis Medications Introduction

11.13.4 Almatica Pharma Revenue in Osteoarthritis Medications Business (2019-2024)

11.13.5 Almatica Pharma Recent Development

11.14 Astellas Pharma

11.14.1 Astellas Pharma Company Detail

11.14.2 Astellas Pharma Business Overview

11.14.3 Astellas Pharma Osteoarthritis Medications Introduction

11.14.4 Astellas Pharma Revenue in Osteoarthritis Medications Business (2019-2024)

11.14.5 Astellas Pharma Recent Development

11.15 Tide Pharmaceutical

11.15.1 Tide Pharmaceutical Company Detail

11.15.2 Tide Pharmaceutical Business Overview

11.15.3 Tide Pharmaceutical Osteoarthritis Medications Introduction

11.15.4 Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2019-2024)

11.15.5 Tide Pharmaceutical Recent Development

11.16 Iroko Pharmaceuticals

11.16.1 Iroko Pharmaceuticals Company Detail

11.16.2 Iroko Pharmaceuticals Business Overview

11.16.3 Iroko Pharmaceuticals Osteoarthritis Medications Introduction

11.16.4 Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2019-2024)

11.16.5 Iroko Pharmaceuticals Recent Development

11.17 Hengrui Pharmaceutical

11.17.1 Hengrui Pharmaceutical Company Detail

11.17.2 Hengrui Pharmaceutical Business Overview

11.17.3 Hengrui Pharmaceutical Osteoarthritis Medications Introduction

11.17.4 Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2019-2024)

11.17.5 Hengrui Pharmaceutical Recent Development

11.18 Abiogen Pharma

11.18.1 Abiogen Pharma Company Detail

11.18.2 Abiogen Pharma Business Overview

11.18.3 Abiogen Pharma Osteoarthritis Medications Introduction

11.18.4 Abiogen Pharma Revenue in Osteoarthritis Medications Business (2019-2024)

11.18.5 Abiogen Pharma Recent Development

11.19 Flexion Therapeutics

11.19.1 Flexion Therapeutics Company Detail

11.19.2 Flexion Therapeutics Business Overview

11.19.3 Flexion Therapeutics Osteoarthritis Medications Introduction

11.19.4 Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2019-2024)

11.19.5 Flexion Therapeutics Recent Development

11.20 Anika Therapeutics

11.20.1 Anika Therapeutics Company Detail

11.20.2 Anika Therapeutics Business Overview

11.20.3 Anika Therapeutics Osteoarthritis Medications Introduction

11.20.4 Anika Therapeutics Revenue in Osteoarthritis Medications Business (2019-2024)

11.20.5 Anika Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Osteoarthritis Medications Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of NSAIDs

Table 3. Key Players of Corticosteroids

Table 4. Key Players of Hyaluronic Acid Injection

Table 5. Key Players of Others

Table 6. Global Osteoarthritis Medications Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Osteoarthritis Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Osteoarthritis Medications Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Osteoarthritis Medications Market Share by Region (2019-2024)

Table 10. Global Osteoarthritis Medications Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Osteoarthritis Medications Market Share by Region (2025-2030)

Table 12. Osteoarthritis Medications Market Trends

Table 13. Osteoarthritis Medications Market Drivers

Table 14. Osteoarthritis Medications Market Challenges

Table 15. Osteoarthritis Medications Market Restraints

Table 16. Global Osteoarthritis Medications Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Osteoarthritis Medications Market Share by Players (2019-2024)

Table 18. Global Top Osteoarthritis Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2023)

Table 19. Ranking of Global Top Osteoarthritis Medications Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Osteoarthritis Medications Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Osteoarthritis Medications Product Solution and Service

Table 23. Date of Enter into Osteoarthritis Medications Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Osteoarthritis Medications Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Osteoarthritis Medications Revenue Market Share by Type (2019-2024)

Table 27. Global Osteoarthritis Medications Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Osteoarthritis Medications Revenue Market Share by Type (2025-2030)

Table 29. Global Osteoarthritis Medications Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Osteoarthritis Medications Revenue Market Share by Application (2019-2024)

Table 31. Global Osteoarthritis Medications Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Osteoarthritis Medications Revenue Market Share by Application (2025-2030)

Table 33. North America Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Osteoarthritis Medications Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Osteoarthritis Medications Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Osteoarthritis Medications Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Osteoarthritis Medications Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Osteoarthritis Medications Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Osteoarthritis Medications Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Osteoarthritis Medications Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Osteoarthritis Medications Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Osteoarthritis Medications Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Osteoarthritis Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Osteoarthritis Medications Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Osteoarthritis Medications Market Size by Country (2025-2030) & (US$ Million)

Table 48. Pfizer Company Detail

Table 49. Pfizer Business Overview

Table 50. Pfizer Osteoarthritis Medications Product

Table 51. Pfizer Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 52. Pfizer Recent Development

Table 53. Johnson & Johnson Company Detail

Table 54. Johnson & Johnson Business Overview

Table 55. Johnson & Johnson Osteoarthritis Medications Product

Table 56. Johnson & Johnson Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 57. Johnson & Johnson Recent Development

Table 58. GlaxoSmithKline Company Detail

Table 59. GlaxoSmithKline Business Overview

Table 60. GlaxoSmithKline Osteoarthritis Medications Product

Table 61. GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 62. GlaxoSmithKline Recent Development

Table 63. Novartis Company Detail

Table 64. Novartis Business Overview

Table 65. Novartis Osteoarthritis Medications Product

Table 66. Novartis Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 67. Novartis Recent Development

Table 68. Bayer Company Detail

Table 69. Bayer Business Overview

Table 70. Bayer Osteoarthritis Medications Product

Table 71. Bayer Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 72. Bayer Recent Development

Table 73. Eli Lilly Company Detail

Table 74. Eli Lilly Business Overview

Table 75. Eli Lilly Osteoarthritis Medications Product

Table 76. Eli Lilly Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 77. Eli Lilly Recent Development

Table 78. Sanofi Company Detail

Table 79. Sanofi Business Overview

Table 80. Sanofi Osteoarthritis Medications Product

Table 81. Sanofi Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 82. Sanofi Recent Development

Table 83. Horizon Pharma Company Detail

Table 84. Horizon Pharma Business Overview

Table 85. Horizon Pharma Osteoarthritis Medications Product

Table 86. Horizon Pharma Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 87. Horizon Pharma Recent Development

Table 88. Abbott Company Detail

Table 89. Abbott Business Overview

Table 90. Abbott Osteoarthritis Medications Product

Table 91. Abbott Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 92. Abbott Recent Development

Table 93. Mylan Company Detail

Table 94. Mylan Business Overview

Table 95. Mylan Osteoarthritis Medications Product

Table 96. Mylan Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 97. Mylan Recent Development

Table 98. Daiichi Sankyo Company Detail

Table 99. Daiichi Sankyo Business Overview

Table 100. Daiichi Sankyo Osteoarthritis Medications Product

Table 101. Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 102. Daiichi Sankyo Recent Development

Table 103. TEVA Company Detail

Table 104. TEVA Business Overview

Table 105. TEVA Osteoarthritis Medications Product

Table 106. TEVA Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 107. TEVA Recent Development

Table 108. Almatica Pharma Company Detail

Table 109. Almatica Pharma Business Overview

Table 110. Almatica Pharma Osteoarthritis Medications Product

Table 111. Almatica Pharma Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 112. Almatica Pharma Recent Development

Table 113. Astellas Pharma Company Detail

Table 114. Astellas Pharma Business Overview

Table 115. Astellas Pharma Osteoarthritis Medications Product

Table 116. Astellas Pharma Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 117. Astellas Pharma Recent Development

Table 118. Tide Pharmaceutical Company Detail

Table 119. Tide Pharmaceutical Business Overview

Table 120. Tide Pharmaceutical Osteoarthritis Medications Product

Table 121. Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 122. Tide Pharmaceutical Recent Development

Table 123. Iroko Pharmaceuticals Company Detail

Table 124. Iroko Pharmaceuticals Business Overview

Table 125. Iroko Pharmaceuticals Osteoarthritis Medications Product

Table 126. Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 127. Iroko Pharmaceuticals Recent Development

Table 128. Hengrui Pharmaceutical Company Detail

Table 129. Hengrui Pharmaceutical Business Overview

Table 130. Hengrui Pharmaceutical Osteoarthritis Medications Product

Table 131. Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 132. Hengrui Pharmaceutical Recent Development

Table 133. Abiogen Pharma Company Detail

Table 134. Abiogen Pharma Business Overview

Table 135. Abiogen Pharma Osteoarthritis Medications Product

Table 136. Abiogen Pharma Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 137. Abiogen Pharma Recent Development

Table 138. Flexion Therapeutics Company Detail

Table 139. Flexion Therapeutics Business Overview

Table 140. Flexion Therapeutics Osteoarthritis Medications Product

Table 141. Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 142. Flexion Therapeutics Recent Development

Table 143. Anika Therapeutics Company Detail

Table 144. Anika Therapeutics Business Overview

Table 145. Anika Therapeutics Osteoarthritis Medications Product

Table 146. Anika Therapeutics Revenue in Osteoarthritis Medications Business (2019-2024) & (US$ Million)

Table 147. Anika Therapeutics Recent Development

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Osteoarthritis Medications Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Osteoarthritis Medications Market Share by Type: 2023 VS 2030

Figure 3. NSAIDs Features

Figure 4. Corticosteroids Features

Figure 5. Hyaluronic Acid Injection Features

Figure 6. Others Features

Figure 7. Global Osteoarthritis Medications Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Osteoarthritis Medications Market Share by Application: 2023 VS 2030

Figure 9. Hospital Pharmacies Case Studies

Figure 10. Retail Pharmacies Case Studies

Figure 11. Online Pharmacies Case Studies

Figure 12. Osteoarthritis Medications Report Years Considered

Figure 13. Global Osteoarthritis Medications Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Osteoarthritis Medications Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Osteoarthritis Medications Market Share by Region: 2023 VS 2030

Figure 16. Global Osteoarthritis Medications Market Share by Players in 2023

Figure 17. Global Top Osteoarthritis Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Osteoarthritis Medications Revenue in 2023

Figure 19. North America Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Osteoarthritis Medications Market Share by Country (2019-2030)

Figure 21. United States Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Osteoarthritis Medications Market Share by Country (2019-2030)

Figure 25. Germany Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Osteoarthritis Medications Market Share by Region (2019-2030)

Figure 33. China Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Osteoarthritis Medications Market Share by Country (2019-2030)

Figure 41. Mexico Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Osteoarthritis Medications Market Share by Country (2019-2030)

Figure 45. Turkey Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Osteoarthritis Medications Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 48. Johnson & Johnson Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 49. GlaxoSmithKline Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 50. Novartis Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 51. Bayer Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 52. Eli Lilly Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 53. Sanofi Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 54. Horizon Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 55. Abbott Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 56. Mylan Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 57. Daiichi Sankyo Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 58. TEVA Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 59. Almatica Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 60. Astellas Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 61. Tide Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 62. Iroko Pharmaceuticals Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 63. Hengrui Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 64. Abiogen Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 65. Flexion Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 66. Anika Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Viscosupplementation for Knee Osteoarthritis Market

Knee Osteoarthritis Treatment Market

Osteoarthritis Pain Market

Osteoarthritis Drugs Market

Osteoarthritis Medications Market

Hip Replacement Market

Rheumatology Therapeutics Market

Total Hip Replacement Market

Psoriatic Arthritis Therapeutics Market

Digital Therapeutics Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Osteoarthritis Medications Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-28E5704

Global Osteoarthritis Medications Market Research Report 2024

FEATURED COMPANIES

Osteoarthritis Medications Market Size

Osteoarthritis Medications Market

Report Scope

Scope of Osteoarthritis Medications Market Report

Chapter Outline

FAQ for this report

How fast is Osteoarthritis Medications Market growing?

What is the Osteoarthritis Medications Market size in 2030?

Who are the main players in the Osteoarthritis Medications Market report?

What are the Application segmentation covered in the Osteoarthritis Medications Market report?

What are the Type segmentation covered in the Osteoarthritis Medications Market report?

FEATURED COMPANIES